New strategies for treating Sjogren's syndrome

Abstract

Sjögren's syndrome (SS) is a complex autoimmune disorder characterized by dryness, fatigue, and systemic involvement, with current treatments largely limited to symptom management. This review explores promising new therapeutic strategies targeting specific molecular pathways implicated in SS pathogenesis, including the roles of B cells, T cells, dendritic cells, cytokines, and neuroendocrine factors. We examine recent advances in drug development and clinical trials focusing on novel biological agents that modulate these pathways, potentially offering a more targeted and effective approach to SS treatment. Ultimately, this review aims to provide an overview of these emerging therapies and their potential to improve outcomes for patients with SS.